The US Food and Drug Administration (FDA) has issued a recall of approximately 580,000 bottles of a commonly prescribed blood pressure medication after tests revealed the presence of a potential cancer-causing impurity. The affected batches were distributed nationwide, and patients are advised to check their medication labels and consult their doctors before making any changes to their treatment.
